Advertisement
Journal of Biological Chemistry
Open access logo
Advanced searchSave search
Research Article| Volume 261, ISSUE 2, P505-507, January 15, 1986

Lycorine: a eukaryotic termination inhibitor?

Open AccessPublished:January 15, 1986DOI:https://doi.org/10.1016/S0021-9258(17)36118-5
Lycorine: a eukaryotic termination inhibitor?
Previous ArticleThe effects of N-ethylmaleimide on the phosphorylation and aggregation of insulin receptors in the isolated plasma membranes of 3T3-F442A adipocytes.
Next ArticleSecretion of rat serum albumin by COS cells transfected with a spliced cDNA gene. A system to study protein sorting.
      This paper is only available as a PDF. To read, Please Download here.
      The effect of the alkaloid lycorine on viral protein synthesis was studied in poliovirus-infected HeLa cells. The incorporation of [3H]leucine was inhibited by lycorine in a dose-dependent way, although lycorine never completely abolished translation. Using polyacrylamide gel electrophoresis, the viral proteins were identified as derived from the P1 (5‘ terminal), P2 (middle), or P3 (3‘ terminal) region of the poliovirus translation unit. The residual labeling of viral proteins in the presence of lycorine was mainly due to synthesis of P1 proteins and slightly less to P2 proteins, while virtually no P3-derived proteins were made. It is suggested that lycorine may act at the level of termination.

      REFERENCES

        • Franklin R.M.
        • Baltimore D.
        Cold Spring Harbor Symp. Quant. Biol. 1962; 27: 175-198
        • Jimenez A.
        • Sanchez L.
        • Vazquez D.
        FEBS Lett. 1975; 60: 66-70
        • Jimenez A.
        • Santos A.
        • Alonso G.
        • Vazquez D.
        Biochim. Biophys. Acta. 1976; 425: 342-348
        • Vanden Berghe D.A.
        • leven M.
        • Vlietinck A.J.
        4th International Conference of Comprehensive Virology, Banff.
        Alberta, Canada1982: 15
        • leven M.
        • Vanden Berghe D.A.
        • Vlietinck A.J.
        Planta Med. 1983; 49: 109-114
        • Kukhanova M.
        • Victorova L.
        • Krayevsky A.
        FEBS Lett. 1983; 160: 129-133
        • Taber R.
        • Rekosh D.
        • Baltimore D.
        J. Virol. 1971; 8: 395-401
        • Rekosh D.
        J. Virol. 1972; 9: 479-487
        • Uehara Y.
        • Hori M.
        • Umezawa H.
        Biochim. Biophys. Acta. 1974; 374: 82-95
        • Vrijsen R.
        • Brioen P.
        • Boeyé A.
        Virology. 1980; 107: 567-569
        • Vrijsen R.
        • Rombaut B.
        • Boeyé A.
        J. Immunol. Methods. 1983; 59: 217-220
        • Caskey C.T.
        Trends Biochem. Sci. 1980; 5: 234-237
        • Kitamura N.
        • Semler B.L.
        • Rothberg P.G.
        • Larsen G.R.
        • Adler C.J.
        • Dorner A.J.
        • Emini E.A.
        • Hanecak R.
        • Lee J.J.
        • van der Werf S.
        • Anderson C.W.
        • Wimmer E.
        Nature. 1981; 291: 547-553

      Article info

      Publication history

      Published online: January 15, 1986

      Identification

      DOI: https://doi.org/10.1016/S0021-9258(17)36118-5

      Copyright

      © 1986 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.

      User license

      Creative Commons Attribution (CC BY 4.0) |
      How you can reuse Information Icon
      Creative Commons Attribution (CC BY 4.0)

      Permitted

      • Read, print & download
      • Redistribute or republish the final article
      • Text & data mine
      • Translate the article
      • Reuse portions or extracts from the article in other works
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      ASBMB  ASBMB  ASBMB  ASBMB

      ISSN 0021-9258
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX